Audience
Healthcare providers and professionals seeking a solution to develop innovative therapies
About Kaleido
The microbiome is implicated in numerous diseases and health conditions. Learn how Kaleido is leading a differentiated approach to translating the promise of the microbiome into solutions for patients. The human microbiome is a community of more than 30 trillion microbes, organisms that include bacteria, viruses, archaea and fungi, which reside on and inside the human body. Over the last decade, research has increased exponentially on the impact the microbiome has on human health, including cardiovascular disease, cancer, diabetes, Parkinson’s disease and allergies. This highly complex microbial ecosystem has been referred to as a “newly discovered organ.” Many other human organs command tens of billions of dollars for therapeutics that treat disease by modulating physiology. From a therapeutic perspective, the microbiome organ remains a largely untapped frontier in healthcare.
Other Popular Alternatives & Related Software
IPM.ai
Specialty and rare diseases have undefined patient populations, with individuals who are undiagnosed or misdiagnosed, healthcare providers who are unaware of disease states and their manifestations, as well as treatment journeys that are not well understood. IPM.ai is an Insights-as-a-Service (IaaS) company that empowers the world’s leading life sciences brands to better understand and improve the lives of patients through the development, clinical study, and commercialization of therapeutic interventions. Maximize commercialization efforts by forecasting market size, competitive landscape, and potential ROI. Uncover ideal patients who are undiagnosed and/or misdiagnosed who may be appropriate for disease interception and therapeutic intervention. Statistically model the number of disease cases present in a particular patient population at a given time. Identify physicians who diagnose and treat ideal patients and influence other health care providers.
Learn more
Mahalo Health
Mahalo Health is a unified digital health platform designed to accelerate the development of patient-centric digital health applications and clinical trials. By offering prebuilt modules. Mahalo enables rapid deployment of white-label apps tailored to specific therapeutic areas. The platform's unified data capabilities include a predictive health engine for disease prediction and diagnosis, a behavior change engine to promote positive patient actions, and a notification engine for timely communications via push, SMS, or email. Ensuring robust security and compliance, Mahalo adheres to standards like HIPAA, GCP, ISO27001, and GDPR. Its services span various therapeutic areas, including diabetes, cognitive health, cardiovascular conditions, musculoskeletal disorders, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH).
Learn more
BrainSightAI
BrainSightAI is a health tech company leveraging artificial intelligence and machine learning to revolutionize brain mapping through AI-based connectomics, generating personalized brain maps. Our VoxelBox products utilize AI-based connectomics to generate personalized brain maps. These tools aim to enhance pre-surgical planning and improve outcomes for patients with brain tumors and other neurological conditions. BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on various brain-based disorders, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our mission is to advance brain science and enhance lives by providing cutting-edge tools for understanding the human brain.
Learn more
MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
Integrations
Company Information
Kaleido
Founded: 2015
United States
kaleido.com/platform/
Videos and Screen Captures
Other Useful Business Software
MongoDB Atlas runs apps anywhere
MongoDB Atlas gives you the freedom to build and run modern applications anywhere—across AWS, Azure, and Google Cloud. With global availability in over 115 regions, Atlas lets you deploy close to your users, meet compliance needs, and scale with confidence across any geography.
Product Details
Platforms Supported
Cloud
Training
Documentation
In Person
Videos
Support
Phone Support
Online
